Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heterogeneity among characteristics of hypereosinophilic syndromes.
Helbig G, Moskwa A, Hus M, Woźniczka K, Wieczorkiewicz A, Dziaczkowska-Suszek J, Soja A, Bartkowska-Chrobok A, Kyrcz-Krzemień S. Helbig G, et al. Among authors: bartkowska chrobok a. J Allergy Clin Immunol. 2010 Jun;125(6):1399-1401.e2. doi: 10.1016/j.jaci.2010.02.024. Epub 2010 Apr 14. J Allergy Clin Immunol. 2010. PMID: 20392489 No abstract available.
Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press.
Helbig G, Majewski M, Wieczorkiewicz A, Bober G, Grzegorczyk J, Dziaczkowska-Suszek J, Soja A, Bartkowska-Chrobok A, Krawczyk M, Krzemień S. Helbig G, et al. Among authors: bartkowska chrobok a. Leuk Res. 2009 Mar;33(3):e1-2. doi: 10.1016/j.leukres.2008.03.034. Epub 2008 May 7. Leuk Res. 2009. PMID: 18466967 No abstract available.
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.
Tudrej P, Olbryt M, Zembala-Nożyńska E, Kujawa KA, Cortez AJ, Fiszer-Kierzkowska A, Pigłowski W, Nikiel B, Głowala-Kosińska M, Bartkowska-Chrobok A, Smagur A, Fidyk W, Lisowska KM. Tudrej P, et al. Among authors: bartkowska chrobok a. Int J Mol Sci. 2018 Jul 17;19(7):2080. doi: 10.3390/ijms19072080. Int J Mol Sci. 2018. PMID: 30018258 Free PMC article.
[A study to determine the safety and efficacy of imatinib mesylate in patients with chronic phase of chronic myeloid leukemia after interferon therapy failure. Four year follow-up].
Hołowiecki J, Konopka L, Bober G, Giebel S, Ceglarek B, Kos K, Stella-Hołowiecka B, Kruzel T, Kopera M, Bartkowska-Chrobok A, Pszenna E, Sikorska A, Pieńikowska-Grela B. Hołowiecki J, et al. Among authors: bartkowska chrobok a. Pol Arch Med Wewn. 2006 Jun;115(6):535-44. Pol Arch Med Wewn. 2006. PMID: 17263225 Clinical Trial. Polish.
Fatal outcome of a rare acute myeloid leukemia with t(8;16)(p11.2;p13.3) and KAT6A::CREBBP gene fusion in a young man.
Spałek A, Bartkowska-Chrobok A, Kulińska-Kozak M, Szymczak B, Dziaczkowska-Suszek J, Helbig G. Spałek A, et al. Among authors: bartkowska chrobok a. Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S410-S414. doi: 10.1016/j.htct.2024.02.023. Epub 2024 Apr 1. Hematol Transfus Cell Ther. 2024. PMID: 38614931 Free PMC article. No abstract available.